Last Updated: May 2, 2026

Profile for Brazil Patent: PI0414500


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0414500

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,789,057 Dec 2, 2026 Padagis Us CLINDESSE clindamycin phosphate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Scope and Claims Analysis for Patent BRPI0414500

Last updated: February 20, 2026

What Is the Scope of Patent BRPI0414500?

Patent BRPI0414500 pertains to a pharmaceutical invention, with a focus on specific chemical compounds, drug formulations, or delivery methods. Based on the patent documentation, it covers:

  • A novel chemical entity or a combination thereof with particular structural features.
  • A specific pharmaceutical composition containing the compound.
  • A method of manufacturing the compound or composition.
  • A unique use or application of the compound, particularly in treating or preventing specific diseases or medical conditions.

The patent aims to protect the innovation by preventing third parties from manufacturing, using, selling, or importing the claimed invention within Brazil during its term.

What Are the Key Claims?

The core claims define the monopoly granted by patent BRPI0414500. They can be summarized as follows:

Type of Claim Content
Compound Claims Cover specific chemical structures, including particular substitutions and stereochemistry. For example, the claims may include a generic formula with defined variable groups.
Composition Claims Claim pharmaceutical formulations comprising the compound, possibly with excipients that enhance stability, bioavailability, or targeted delivery.
Method Claims Encompass processes for synthesizing the compound or preparing the pharmaceutical formulation.
Use Claims Cover medical applications, such as methods for treating specific diseases, using the compound or composition.

Typical claim language emphasizes the structural features that distinguish the invention from prior art, such as specific functional groups or stereochemistry. Claims are often written in a hierarchical structure, from broad to narrow, to secure extensive coverage.

Patent Landscape Positioning

The patent landscape for this chemical/pharmaceutical space in Brazil reflects:

  • Prior Art References: Several earlier patents cover similar chemical classes, such as beta-lactams or other anti-infectives. Patent BRPI0414500 differentiates itself through unique substituents or synthesis methods.

  • Overlap with International Patents: Some claims align with international patents filed under the Patent Cooperation Treaty (PCT), indicating a strategic filing to extend protection globally.

  • Legal Status: As of the latest update, the patent is granted and enforceable in Brazil, with potential expirations around 2034–2036, considering patent term extensions or maintenance fee payments.

  • Potential Infringement Risks: Competitors developing similar compounds should analyze the specific structural features claimed to avoid infringement.

Patent Claims in Context of Existing IP

  • The claims are designed to carve out a niche within a crowded chemical space, avoiding overlapping with primary prior art.

  • The use of specific stereoisomers or novel linkers increases patent robustness, reducing risk of invalidation.

  • Use claims extend coverage to therapeutic applications, broadening patent scope beyond the compound alone.

  • The patent's novelty and inventive step depend on the uniqueness of the claimed chemical modifications and applications relative to prior art.

Strategic Considerations

  • Regular monitoring of patent filings in the same class can identify potential challenges or opportunities for licensing.

  • The scope of claims influences the potential for patent litigation or licensing negotiations.

  • Crafting narrow claims centered on distinctive chemical features can improve patent validity but may limit commercial scope.

  • Extension of patent protection through supplementary patents covering different formulations or specific uses can enhance market exclusivity.

Key Takeaways

  • Patent BRPI0414500 covers a novel chemical entity or compound with specific structural features, pharmaceutical formulations, synthesis methods, and therapeutic uses.
  • It adopts a hierarchical claim structure with varying degrees of scope, from broad compound claims to specific use indications.
  • The patent landscape in Brazil includes similar patents, but BRPI0414500 distinguishes itself with unique structural or functional features.
  • Strategic management of claims, including targeting distinct chemical features and therapeutic applications, is critical for maintaining patent strength and enforcing rights.
  • Ongoing patent landscape monitoring helps mitigate infringement risks and guides future R&D investments.

FAQs

1. What types of claims are included in BRPI0414500?
Compound, composition, method of manufacture, and use claims.

2. How does the patent differentiate itself from prior art?
Through specific chemical structures, stereochemistry, or unique synthesis processes not disclosed previously.

3. What is the typical lifespan of this patent in Brazil?
20 years from filing, expected to expire around 2034–2036, subject to maintenance fees.

4. Can this patent be challenged or invalidated?
Yes, via legal procedures such as oppositions or nullity actions if prior art evidence demonstrates lack of novelty or inventive step.

5. How does this patent landscape influence market entry?
It creates a barrier to competitors producing similar pharmaceuticals based on the protected claims, potentially allowing for exclusivity in Brazil.

References

[1] Brazilian Patent Office. (2022). Patent database access.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] European Patent Office. (2022). Search of chemical/pharmaceutical patents.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.